ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting – update

ISDA letter to ESMA and National Competent Authorities (NCAs) providing an update on anticipated challenges for EMIR reporting of OTC Derivatives from February 12, 2014.

Appendix 1: Update on each of the industry issues and challenges advised previously (Appendix 2).
Appendix 2: Original list of industry issues and challenges.

Response to Eurosystem Consultation on Appia

On April 22, ISDA responded to the Eurosystem consultation on the Appia roadmap. ISDA broadly supports the roadmap and its high level principles, while recommending that the principle on market access and integration should be expanded to explicitly address interoperability...